Project Details
| Status | Active |
|---|---|
| Effective start/end date | 2/10/26 → 2/9/27 |
Funding
- DANA-FARBER CANCER INSTITUTE
HM2026-01- A Phase 2 Study of Epcoritamab, Zanubrutinib, and Rituximab (EZR) for treatment of relapsed or refractory follicular lymphoma or marginal zone lymphoma
- Desai, Sanjal (PI)
Project: Research project